Résultats de la recherche - 130 results

De TDI-registratie in België, Jaarlijks rapport, Registratiejaar 2019.

Accession Number: D/2020/14.440/88 Keywords: illicit drugs Treatment Demand Indicator Abstract: In dit rapport presenteren we de gegevens voor 2019 inzake de vraag naar behandeling in verband met het gebruik ...

Reitox national reporting to EMCDDA on drugs and drug addiction, 2020

at Sciensano. The annual reporting comprises of 10 Chapters: Chapter 1: Drug Policy Chapter 2: Legal Framework Chapter 3: Drug use in (the) (sub)population(s) Chapter 4: Prevention Chapter 5: Treatment Chapter 6: ...

Annual report Belgian Cystic Fibrosis Registry 2018

period at about 3.5% over the years since 2014.   Thanks to improved disease management and novel treatments, the life expectancy and the quality of life of patients with CF has improved significantly when ...

Annual Report Belgian Cystic Fibrosis Registry 2017

2014. Thanks to improved disease management and novel treatments, the life expectancy and the quality of life of patients with CF has improved significantly when compared to CF cohorts a decade or two ...

Characterization and hazard identification of substandard and falsified antimicrobials encountered in Belgium

essential life-saving medicines could cause treatment failures, antimicrobial resistance and drug side effects [1]. Therefore, validated and robust analytical tools enabling the identification and ...

Comparative dissolution study on substandard and falsified antibiotics encountered in Belgium

developing and developed countries, posing a growing threat to public health. It has been demonstrated that SF products of these essential life-saving medicines could cause treatment failures, antimicrobial ...

Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017

(95% CI: 27.3-29.0%). Medical prophylaxis, surgical prophylaxis and treatment of HAI s were reported as indication in 6.2%, 13.5% and 24.2% of the prescribed antimicrobial agents (N=4103), respectively. ...

Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs

(480 000 new cases), impeding the treatment of infected patients. Current TB drug resistance research is mainly focused on the genomic level, using WGS to search for resistance-causing mutations. ...

Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs

treatment of infected patients. Current TB drug resistance research is mainly focused on the genomic level, using WGS to search for resistance-causing mutations. However, transcriptional analyses can be ...

QR code

QR code for this page URL